Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
2.899
-0.041 (-1.41%)
Nov 21, 2024, 1:04 PM EST - Market open
Lisata Therapeutics Employees
Lisata Therapeutics had 25 employees as of December 31, 2023. The number of employees decreased by 2 or -7.41% compared to the previous year.
Employees
25
Change (1Y)
-2
Growth (1Y)
-7.41%
Revenue / Employee
n/a
Profits / Employee
-$829,600
Market Cap
24.12M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Neuronetics | 203 |
Spectral AI | 78 |
IN8bio | 31 |
NeurAxis | 19 |
NEXGEL | 19 |
Tempest Therapeutics | 17 |
AEON Biopharma | 10 |
Cadrenal Therapeutics | 4 |
LSTA News
- 2 days ago - Lisata Therapeutics Wins 2024 BioTech Breakthrough Award for ‘Specialized BioTherapeutics Company of the Year' - GlobeNewsWire
- 8 days ago - Lisata Therapeutics, Inc. (LSTA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Lisata Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 15 days ago - Lisata Therapeutics and Valo Therapeutics Announce Preclinical Research Collaboration - GlobeNewsWire
- 15 days ago - Lisata Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update on Tuesday, November 12, 2024 - GlobeNewsWire
- 21 days ago - Lisata Therapeutics to Participate in Upcoming November 2024 Industry and Investor Events - GlobeNewsWire
- 24 days ago - Lisata Therapeutics Announces Sponsored Preclinical Research Agreement with the University of Cincinnati to Study Certepetide for the Treatment of Endometriosis - GlobeNewsWire
- 2 months ago - Lisata Therapeutics to Participate in Upcoming September 2024 Industry and Investor Events - GlobeNewsWire